Traditional MedicareCoverageMedium impact
Multimarker Serum Tests Related to Ovarian Cancer Testing
Medicare/CMS - LCD·Oncology, OB-GYN·Local Coverage Determination
Effective date
Apr 1, 2026
We identified it
Jul 28, 2026
Summary
Unable to provide complete analysis. The policy content was not included in the provided information. While metadata indicates this is a LOCAL COVERAGE DETERMINATION (LCD L38371) from WellPoint Federal for Multimarker Serum Tests Related to Ovarian Cancer Testing, effective 4/1/2026, the actual policy text detailing coverage criteria, billing codes, and requirements is missing. Access the full policy at the provided CMS link to extract specific codes and requirements.
Action Required
URGENT - By 3/1/2026: Billing team must retrieve and review the complete policy text from https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=38371&ver=13. Once obtained, identify all affected CPT/HCPCS codes for multimarker serum tests related to ovarian cancer (likely OVA1, OvaCheck, or similar). Determine coverage criteria, prior authorization requirements, and any documentation mandates. Update billing software, encounter forms, and provider communication accordingly. Failure to implement coverage changes will result in claim denials for this service line effective 4/1/2026.